Tu CX - Search Results

1

Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.

Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: tu cx. J Pharmacol Exp Ther. 2010 Aug;334(2):489-99. doi: 10.1124/jpet.110.165654. Epub 2010 May 14. J Pharmacol Exp Ther. 2010. PMID: 20472666

2

Antimetastatic activity of MONCPT in preclinical melanoma mice model.

Yang XC, Tu CX, Luo PH, Zhu H, Zhu DF, Wu HH, Zhou XL, Lu W, He QJ, Yang B. Yang XC, et al. Among authors: tu cx. Invest New Drugs. 2010 Dec;28(6):800-11. doi: 10.1007/s10637-009-9323-8. Epub 2009 Sep 30. Invest New Drugs. 2010. PMID: 19789842

3

MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway.

Ying M, Tu C, Ying H, Hu Y, He Q, Yang B. Ying M, et al. J Pharmacol Exp Ther. 2008 Jun;325(3):758-65. doi: 10.1124/jpet.107.135657. Epub 2008 Mar 6. J Pharmacol Exp Ther. 2008. PMID: 18323457

4

Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo.

Ding W, Cai T, Zhu H, Wu R, Tu C, Yang L, Lu W, He Q, Yang B. Ding W, et al. Cancer Lett. 2010 Jul 28;293(2):158-66. doi: 10.1016/j.canlet.2010.01.005. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137855

5

Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases.

Ren DY, Yuan XR, Tu CX, Shen JL, Li YW, Yan AH, Ru Y, Han HY, Yang YM, Liu Y, Li HY. Ren DY, et al. Among authors: tu cx. Front Pharmacol. 2021 Dec 20;12:726908. doi: 10.3389/fphar.2021.726908. eCollection 2021. Front Pharmacol. 2021. PMID: 34987381 Free PMC article. Review.

6

Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.

Wang XH, Liao B, Hu WJ, Tu CX, Xiang CL, Hao SH, Mao XH, Qiu XM, Yang XJ, Yue X, Kuang M, Peng BG, Li SQ. Wang XH, et al. Among authors: tu cx. Oncologist. 2020 Oct;25(10):e1552-e1561. doi: 10.1634/theoncologist.2019-0766. Epub 2020 Aug 6. Oncologist. 2020. PMID: 32663354 Free PMC article.

7

DNAJA4 deficiency augments hyperthermia-induced Clusterin and ERK activation: two critical protective factors of human keratinocytes from hyperthermia-induced injury.

Wei ZD, Sun YZ, Tu CX, Qi RQ, Huo W, Chen HD, Gao XH. Wei ZD, et al. Among authors: tu cx. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2308-2317. doi: 10.1111/jdv.16432. Epub 2020 May 15. J Eur Acad Dermatol Venereol. 2020. PMID: 32277496

8

[In vitro metabolism of daphnetin in rat liver S9 fractions].

Liang SC, Ge GB, Xia YL, Qi XY, Wang AX, Tu CX, Yang L. Liang SC, et al. Among authors: tu cx. Yao Xue Xue Bao. 2017 Feb;52(2):291-5. Yao Xue Xue Bao. 2017. PMID: 29979523 Chinese.

9

Characteristics of peripheral blood CD4+CD25+ regulatory T cells and related cytokines in severe atopic dermatitis.

Zhang YY, Wang AX, Xu L, Shen N, Zhu J, Tu CX. Zhang YY, et al. Among authors: tu cx. Eur J Dermatol. 2016 Jun 1;26(3):240-6. doi: 10.1684/ejd.2015.2709. Eur J Dermatol. 2016. PMID: 27184163

10

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis.

Liu P, Zhao Y, Mu ZL, Lu QJ, Zhang L, Yao X, Zheng M, Tang YW, Lu XX, Xia XJ, Lin YK, Li YZ, Tu CX, Yao ZR, Xu JH, Li W, Lai W, Yang HM, Xie HF, Han XP, Xie ZQ, Nong X, Guo ZP, Deng DQ, Shi TX, Zhang JZ. Liu P, et al. Among authors: tu cx. Chin Med J (Engl). 2016 Apr 5;129(7):757-62. doi: 10.4103/0366-6999.178960. Chin Med J (Engl). 2016. PMID: 26996468 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters